Assignee

SAREPTA THERAPEUTICS INC

US·102 granted patents·109 pending applications·994 citations·filing 2012–2025

Technology mixC12N190 A61P184 A61K165 C07K47 C07F38 C07H25

Top patents by PatentIndex Score

211 records

0199US9416361B2Splice-region antisense composition and methodSAREPTA THERAPEUTICS INC·Filed 2014·Granted Aug 16, 2016·90 cites·16 claims
0299US8895722B2Splice-region antisense composition and methodSAREPTA THERAPEUTICS INC·Filed 2013·Granted Nov 25, 2014·86 cites·10 claims
0399US8835402B2Compound and method for treating myotonic dystrophySAREPTA THERAPEUTICS INC·Filed 2013·Granted Sep 16, 2014·91 cites·10 claims
0498US10533174B2Splice-region antisense composition and methodSAREPTA THERAPEUTICS INC·Filed 2017·Granted Jan 14, 2020·31 cites·13 claims
0598US9447417B2Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2015·Granted Sep 20, 2016·61 cites·4 claims
0698US9447416B2Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2015·Granted Sep 20, 2016·40 cites·8 claims
0798US9434948B2Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2015·Granted Sep 6, 2016·52 cites·8 claims
0898US9234198B1Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2015·Granted Jan 12, 2016·35 cites·8 claims
0998US8865883B2Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2013·Granted Oct 21, 2014·95 cites·21 claims
1097US9453225B2Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2015·Granted Sep 27, 2016·23 cites·4 claims
1197US9217148B2Exon skipping compositions for treating muscular dystrophySAREPTA THERAPEUTICS INC·Filed 2014·Granted Dec 22, 2015·45 cites·6 claims
1296US11097011B2Peptide oligonucleotide conjugatesSAREPTA THERAPEUTICS INC·Filed 2020·Granted Aug 24, 2021·4 cites·17 claims
1395US10888578B2Exon skipping oligomer conjugates for muscular dystrophySAREPTA THERAPEUTICS INC·Filed 2017·Granted Jan 12, 2021·6 cites·22 claims
1495US10337003B2Compositions for treating muscular dystrophySAREPTA THERAPEUTICS INC·Filed 2016·Granted Jul 2, 2019·46 cites·12 claims
1594US11672871B2Peptide oligonucleotide conjugatesSAREPTA THERAPEUTICS INC·Filed 2021·Granted Jun 13, 2023·2 cites·26 claims
1694US10364431B2Compositions for treating muscular dystrophySAREPTA THERAPEUTICS INC·Filed 2017·Granted Jul 30, 2019·40 cites·22 claims
1794US10006031B2Antisense composition and method for treating muscle atrophySAREPTA THERAPEUTICS INC·Filed 2016·Granted Jun 26, 2018·7 cites·11 claims
1894US9506058B2Compositions for treating muscular dystrophySAREPTA THERAPEUTICS INC·Filed 2014·Granted Nov 29, 2016·69 cites·29 claims
1994US9249243B2Antibacterial antisense oligonucleotide and methodSAREPTA THERAPEUTICS INC·Filed 2013·Granted Feb 2, 2016·13 cites·18 claims
2093US11384105B2Processes for preparing oligomersSAREPTA THERAPEUTICS INC·Filed 2020·Granted Jul 12, 2022·3 cites·8 claims
2193US10675356B2Peptide oligonucleotide conjugatesSAREPTA THERAPEUTICS INC·Filed 2016·Granted Jun 9, 2020·6 cites·34 claims
2293US9278987B2Functionally-modified oligonucleotides and subunits thereofSAREPTA THERAPEUTICS INC·Filed 2012·Granted Mar 8, 2016·12 cites·16 claims
2393US2025154507A1Multiple exon skipping compositions for dmdSAREPTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
2492US11071749B2Oligonucleotide analogues targeting human LMNASAREPTA THERAPEUTICS INC·Filed 2019·Granted Jul 27, 2021·3 cites·12 claims
2592US9833468B2Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNASAREPTA THERAPEUTICS INC·Filed 2016·Granted Dec 5, 2017·12 cites·51 claims
2691US9326992B2Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNASAREPTA THERAPEUTICS INC·Filed 2012·Granted May 3, 2016·16 cites·86 claims
2790US11225662B2Peptide oligonucleotide conjugatesSAREPTA THERAPEUTICS INC·Filed 2019·Granted Jan 18, 2022·2 cites·37 claims
2890US11000600B2Exon skipping oligomer conjugates for muscular dystrophySAREPTA THERAPEUTICS INC·Filed 2018·Granted May 11, 2021·6 cites·22 claims
2990US10875880B2Processes for preparing oligomersSAREPTA THERAPEUTICS INC·Filed 2017·Granted Dec 29, 2020·5 cites·22 claims
3090US9862946B2Peptide oligonucleotide conjugatesSAREPTA THERAPEUTICS INC·Filed 2015·Granted Jan 9, 2018·6 cites·20 claims
3190US9499583B2Antibacterial antisense oligonucleotide and methodSAREPTA THERAPEUTICS INC·Filed 2015·Granted Nov 22, 2016·3 cites·2 claims
3290US9469664B2Oligonucleotide analogues having modified intersubunit linkages and/or terminal groupsSAREPTA THERAPEUTICS INC·Filed 2014·Granted Oct 18, 2016·6 cites·18 claims
3390US9394323B2Antisense antiviral compound and method for treating influenza viral infectionSAREPTA THERAPEUTICS INC·Filed 2014·Granted Jul 19, 2016·5 cites·36 claims
3490US2025236869A1Exon skipping compositions for treating muscular dystrophySAREPTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
3590US2025145991A1Exon skipping compositions for treating muscular dystrophySAREPTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
3689US10758629B2Exon skipping oligomer conjugates for muscular dystrophySAREPTA THERAPEUTICS INC·Filed 2018·Granted Sep 1, 2020·2 cites·4 claims
3789US10479996B2Antisense antiviral compound and method for treating ss/RNA viral infectionSAREPTA THERAPEUTICS INC·Filed 2014·Granted Nov 19, 2019·4 cites·9 claims
3889US9790499B2Functionally-modified oligonucleotides and subunits thereofSAREPTA THERAPEUTICS INC·Filed 2016·Granted Oct 17, 2017·3 cites·16 claims
3988US11395855B2Exon skipping oligomer conjugates for muscular dystrophySAREPTA THERAPEUTICS INC·Filed 2021·Granted Jul 26, 2022·1 cites·6 claims
4088US10961262B2Processes for preparing phosphorodiamidate morpholino oligomersSAREPTA THERAPEUTICS INC·Filed 2017·Granted Mar 30, 2021·4 cites·16 claims
4188US10626396B2Antisense composition and method for treating muscle atrophySAREPTA THERAPEUTICS INC·Filed 2018·Granted Apr 21, 2020·2 cites·13 claims
4286US11338041B2Exon skipping oligomer conjugates for muscular dystrophySAREPTA THERAPEUTICS INC·Filed 2020·Granted May 24, 2022·1 cites·22 claims
4386US10907154B2Exon skipping compositions for treating muscular dystrophySAREPTA THERAPEUTICS INC·Filed 2018·Granted Feb 2, 2021·1 cites·4 claims
4486US10765760B2Exon skipping oligomer conjugates for muscular dystrophySAREPTA THERAPEUTICS INC·Filed 2018·Granted Sep 8, 2020·1 cites·4 claims
4586US10144762B2Antibacterial antisense oligonucleotide and methodSAREPTA THERAPEUTICS INC·Filed 2016·Granted Dec 4, 2018·2 cites·14 claims
4685US10947533B2Processes for preparing phosphorodiamidate morpholino oligomersSAREPTA THERAPEUTICS INC·Filed 2017·Granted Mar 16, 2021·3 cites·21 claims
4785US10927378B2Compound and method for treating myotonic dystrophySAREPTA THERAPEUTICS INC·Filed 2018·Granted Feb 23, 2021·1 cites·32 claims
4885US9944926B2Induced exon inclusion in spinal muscle atrophySAREPTA THERAPEUTICS INC·Filed 2012·Granted Apr 17, 2018·10 cites·18 claims
4985US9066967B2Oligonucleotide analogues targeting human LMNASAREPTA THERAPEUTICS INC·Filed 2012·Granted Jun 30, 2015·4 cites·86 claims
5084US12239715B2Peptide oligonucleotide conjugatesSAREPTA THERAPEUTICS INC·Filed 2023·Granted Mar 4, 2025·0 cites·27 claims

Showing the top 50 of 211 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when SAREPTA THERAPEUTICS INC files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →